www.fdanews.com/articles/196815-adaptvac-taps-agc-biologics-to-manufacture-its-covid-19-vaccine
AdaptVac Taps AGC Biologics to Manufacture its COVID-19 Vaccine
April 27, 2020
AdaptVac has entered a manufacturing agreement with ACG Biologics for the manufacture and eventual scaling-up of its candidate for a COVID-19 vaccine.
The partners aim to accelerate the development and manufacture of AdaptVac’s capsid-Virus Like Particle (cVLP) vaccine for use against the coronavirus.
AdaptVac hopes to launch a clinical trial of the vaccine candidate by the end of the year.